Chemours (CC): Opteon Not Fully Discounted, Raising PT - Susquehanna
Tweet Send to a Friend
Susquehanna analyst, Don Carson, reiterated his Positive rating on shares of Chemours (NYSE: CC) and raised his price target to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


